Shuttle Pharmaceuticals Holdings, Inc. /
1542770 BC Ltd.
Shuttle Pharmaceuticals Holdings agrees to purchase Molecule assets
Source for the buyer and target: Shuttle Pharmaceuticals Holdings, Inc.
For the buyer and target.
“This Binding Term Sheet (this “ Term Sheet ”) sets forth our current proposal with regard to a business combination (the “ Transaction ”) between 1542770 BC Ltd., a Canadian limited liability company (“ Molecule ”) and Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (“ Shuttle ”).”
Published 21 Oct 2025
Open the sourceWhat happened
Shuttle Pharmaceuticals Holdings, Inc. entered into a binding term sheet with 1542770 BC Ltd. for the purchase of substantially all of Molecule’s assets and liabilities. [01]
The purchase price is $10,000,000, payable over time in cash and shares of common stock, subject to milestones. Completion depends on definitive agreements, board approval and due diligence. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Shuttle Pharmaceuticals Holdings agrees to purchase Molecule assets
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Published by Shuttle Pharmaceuticals Holdings, Inc.
The source this page is built from.
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly